IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models.
Stip MC, Evers M, Nederend M, Chan C, Reiding KR, Damen MJ, Heck AJR, Koustoulidou S, Ramakers R, Krijger GC, de Roos R, Souteyrand E, Cornel AM, Dierselhuis MP, Jansen M, de Boer M, Valerius T, van Tetering G, Leusen JHW, Meyer-Wentrup F.
Stip MC, et al. Among authors: chan c.
J Immunother Cancer. 2023 Jul;11(7):e006948. doi: 10.1136/jitc-2023-006948.
J Immunother Cancer. 2023.
PMID: 37479484
Free PMC article.